Elizabeth A. Rich

3.9k total citations
53 papers, 3.3k citations indexed

About

Elizabeth A. Rich is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Elizabeth A. Rich has authored 53 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 18 papers in Virology and 17 papers in Infectious Diseases. Recurrent topics in Elizabeth A. Rich's work include HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (12 papers) and Tuberculosis Research and Epidemiology (11 papers). Elizabeth A. Rich is often cited by papers focused on HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (12 papers) and Tuberculosis Research and Epidemiology (11 papers). Elizabeth A. Rich collaborates with scholars based in United States, Japan and Bangladesh. Elizabeth A. Rich's co-authors include Jerrold J. Ellner, Hua Xiao, Zahra Toossi, Kuan-Teh Jeang, Eduardo Sada, Stephan Schwander, Robert S. Wallis, Martha Torres, Charles S. Hirsch and Candace K. Finegan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Elizabeth A. Rich

52 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth A. Rich United States 31 1.4k 1.3k 1.1k 983 767 53 3.3k
Michael Fung United States 32 627 0.5× 1.6k 1.2× 574 0.5× 1.0k 1.0× 626 0.8× 53 3.4k
Thomas Harrer Germany 33 1.2k 0.9× 1.6k 1.2× 510 0.5× 1.5k 1.5× 1.1k 1.5× 114 3.8k
C. V. Paya United States 37 1.2k 0.9× 1.2k 0.9× 2.7k 2.5× 631 0.6× 820 1.1× 69 5.1k
Gersende Caron France 28 592 0.4× 2.2k 1.6× 708 0.6× 909 0.9× 1.1k 1.4× 70 4.3k
Ali Ahmad Canada 36 394 0.3× 1.7k 1.3× 664 0.6× 673 0.7× 757 1.0× 105 3.4k
Julia L. Hurwitz United States 32 985 0.7× 1.2k 0.9× 1.4k 1.3× 284 0.3× 573 0.7× 136 3.4k
Elisa Vicenzi Italy 36 1.2k 0.9× 2.0k 1.5× 983 0.9× 1.8k 1.9× 783 1.0× 136 4.2k
Jian Zheng United States 34 1.4k 1.0× 1.8k 1.3× 743 0.7× 317 0.3× 645 0.8× 105 3.8k
Nicole Israël France 30 388 0.3× 1.1k 0.8× 542 0.5× 847 0.9× 747 1.0× 64 2.6k
Daniel Scott‐Algara France 31 653 0.5× 1.8k 1.3× 903 0.8× 1.2k 1.2× 485 0.6× 100 3.1k

Countries citing papers authored by Elizabeth A. Rich

Since Specialization
Citations

This map shows the geographic impact of Elizabeth A. Rich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Rich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Rich more than expected).

Fields of papers citing papers by Elizabeth A. Rich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Rich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Rich. The network helps show where Elizabeth A. Rich may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Rich

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Rich. A scholar is included among the top collaborators of Elizabeth A. Rich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Rich. Elizabeth A. Rich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynch, Thomas B., et al.. (2023). Quadriceps Dysfunction Following Joint Preservation Surgery: A Review of the Pathophysiologic Basis and Mitigation Strategies. Current Reviews in Musculoskeletal Medicine. 16(8). 338–345. 1 indexed citations
2.
Aung, Htin, et al.. (2001). Dysregulation of β-Chemokines in the Lungs of HIV-1–Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(4). 305–314. 6 indexed citations
4.
Schwander, Stephan, Martha Torres, Magdalena Tary‐Lehmann, et al.. (2000). Pulmonary Mononuclear Cell Responses to Antigens of Mycobacterium tuberculosis in Healthy Household Contacts of Patients with Active Tuberculosis and Healthy Controls from the Community. The Journal of Immunology. 165(3). 1479–1485. 50 indexed citations
5.
Jeang, Kuan-Teh, Hua Xiao, & Elizabeth A. Rich. (1999). Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat. Journal of Biological Chemistry. 274(41). 28837–28840. 353 indexed citations
6.
Rich, Elizabeth A.. (1998). Activation-Inactivation of HIV-1 in the Lung. Journal of Biomedical Science. 5(1). 1–10. 2 indexed citations
8.
Guay, Laura, Juan Sierra‐Madero, Candace K. Finegan, & Elizabeth A. Rich. (1997). Mediation of Entry of Human Immunodeficiency Virus-1 into Alveolar Macrophages by CD4 Without Facilitation by Surfactant-Associated Protein-A. American Journal of Respiratory Cell and Molecular Biology. 16(4). 421–428. 10 indexed citations
9.
Tan, Jiahong, David H. Canaday, W. Henry Boom, et al.. (1997). Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. The Journal of Immunology. 159(1). 290–297. 105 indexed citations
10.
Toossi, Zahra, et al.. (1996). Decreased production of TGF-β 1 by human alveolar macrophages compared with blood monocytes. The Journal of Immunology. 156(9). 3461–3468. 67 indexed citations
11.
Abbud, Rula, Candace K. Finegan, Laura Guay, & Elizabeth A. Rich. (1995). Enhanced Production of Human Immunodeficiency Virus Type 1 by In Vitro-Infected Alveolar Macrophages from Otherwise Healthy Cigarette Smokers. The Journal of Infectious Diseases. 172(3). 859–863. 53 indexed citations
12.
13.
Rich, Elizabeth A., et al.. (1994). Lymphocytic Alveolitis in a Crematorium Worker. CHEST Journal. 105(2). 617–619. 3 indexed citations
14.
Boom, W. Henry, et al.. (1993). Characterization of Suppressor Function of Human Alveolar Macrophages for T Lymphocyte Responses to Phytohemagglutinin: Cellular Selectivity, Reversibility, and Early Events in T Cell Activation. American Journal of Respiratory Cell and Molecular Biology. 8(1). 89–97. 37 indexed citations
15.
Miller, Carole B., et al.. (1993). Transient Normalization of Lymphocyte Blastogenic and Specific Antibody Responses Following Boosting of Healthy Elderly Subjects With Tetanus Toxoid. Journal of Gerontology. 48(1). M19–M25. 16 indexed citations
16.
Rich, Elizabeth A., et al.. (1992). Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1).. Journal of Clinical Investigation. 89(1). 176–183. 194 indexed citations
17.
Rich, Elizabeth A., et al.. (1991). Requirement for Cell-to-Cell Contact for the Immunosuppressive Activity of Human Alveolar Macrophages. American Journal of Respiratory Cell and Molecular Biology. 4(3). 287–294. 37 indexed citations
18.
Krutmann, Jean, et al.. (1990). Cell membrane is a major locus for ultraviolet B-induced alterations in accessory cells.. Journal of Clinical Investigation. 85(5). 1529–1536. 67 indexed citations
19.
Rich, Elizabeth A., et al.. (1989). Dyscoordinate Expression of Tumor Necrosis Factor-alpha by Human Blood Monocytes and Alveolar Macrophages. American Review of Respiratory Disease. 139(4). 1010–1016. 71 indexed citations
20.
Rich, Elizabeth A., David J. Tweardy, Hiroshi Fujiwara, & Jerrold J. Ellner. (1987). Spectrum of Immunoregulatory Functions and Properties of Human Alveolar Macrophages. American Review of Respiratory Disease. 136(2). 258–265. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026